STOCK TITAN

LiveCare Inc.(OTCMKTS: LVCE) Enters Hypertension Market, Enhancing Healthcare Monitoring for U.S. Adults

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
LiveCare Inc. (LVCE) launches an innovative blood pressure cuff device to combat high blood pressure, diabetes, and heart conditions. The device offers real-time health monitoring and human interaction, setting a new standard in healthcare.
Positive
  • None.
Negative
  • None.

Venice, FL, USA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTCMKTS: LVCE), a leading innovator in healthcare solutions, proudly announces the launch of a state-of-the-art blood pressure cuff device. This device represents a significant step forward in combating high blood pressure, a prevalent condition affecting roughly one-third of adults in the United States. Specifically designed for individuals with high blood pressure, congestive heart failure, hypertension, and diabetes, this cutting-edge device offers a convenient and effective way to monitor health.

A distinguishing feature of the LiveCare Health approach is the real-time transmission of device readings to the health center. What sets LiveCare Health apart is its commitment to real human interaction with patients, offering around-the-clock support to ensure the best outcomes and establish deep, meaningful relationships. Patients enjoy direct access to the LiveCare team without the need for appointments, circumventing automated responses for the warmth of a live conversation at any hour. This dedication to immediate, personal support nurtures a sense of security and happiness among patients, fostering loyalty with both patients and partnering physicians. LiveCare Health's comprehensive program is uniquely tailored to engage patients through direct, real-time interaction, providing a supportive presence even in moments of loneliness. This model emphasizes a commitment to genuine care and connection, setting a new standard in the healthcare experience.

High blood pressure, often dubbed the "silent killer," poses a significant health risk leading to severe complications such as heart attacks and strokes, often without prior symptoms. LiveCare Inc.'s latest innovation aims to tackle this issue head-on by offering an accessible, user-friendly solution that encourages regular monitoring and management of blood pressure levels.

The introduction of this blood pressure cuff device supported by the health center underscores LiveCare Inc.'s dedication to broadening its range of services to better address chronic illnesses, thereby enhancing life quality for those affected. Integrating this device with its suite of services for elderly individuals with diabetes, LiveCare Inc. is set to make a profound impact on public health.

"The launch of our blood pressure cuff device is a pivotal moment in our journey to redefine chronic illness management," said Max Rockwell, CEO of LiveCare Inc. "Making this technology available to millions of Americans living with high blood pressure and other chronic conditions is a key step toward reducing the prevalence of life-threatening diseases and promoting a healthier society while staying connected to a caring professional 24/7."

The demand for blood pressure monitoring devices is substantial and expanding, fueled by growing recognition of the critical role of early hypertension detection and management. With an estimated 75 million American adults diagnosed with high blood pressure, the potential impact of LiveCare Inc.'s new device is considerable. This launch not only solidifies LiveCare Inc.'s position as a leader in healthcare technology but also opens up significant growth prospects for the company.

By leveraging state-of-the-art technology and a profound understanding of the needs of those with chronic illnesses, LiveCare Inc. is committed to enhancing patient outcomes and minimizing healthcare costs. The blood pressure cuff device is now available, offering a pragmatic and efficient solution for millions of Americans striving to manage their health amid chronic conditions.

For further information about LiveCare Inc. and the blood pressure cuff device, please visit www.livecarehealth.com.

About LiveCare Inc.

LiveCare Inc. (OTCMKTS: LVCE) is a publicly-traded company dedicated to delivering innovative healthcare solutions that significantly improve the quality of life for individuals with chronic illnesses. Focused on cutting-edge technology and personalized care, LiveCare Inc. is leading the way in transforming healthcare delivery for the better.

Safe Harbor Statement

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. Without limiting the generality of the foregoing, words such as "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate", "Projection", or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict and many of which are beyond the control of LiveCare Inc. Actual results may differ from those projected in the forward-looking statements due to risks and uncertainties, as well as other risk factors that are included in the Company's filings with the U.S. Securities and Exchange Commission. Although LiveCare Inc believes that the assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the results contemplated in forward-looking statements will be realized. In light of the significant uncertainties inherent in the forward-looking information included herein, the inclusion of such information should not be regarded as a representation by LiveCare Inc or any other person that their objectives or plans will be achieved. LiveCare Inc does not undertake any obligation to revise the forward-looking statements contained herein to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contact Information:
LIVECARE Phone: (800) 345-0491
Livecare Website: https://www.livecarehealth.com/investors


FAQ

What did LiveCare Inc. (LVCE) announce?

LiveCare Inc. announced the launch of a state-of-the-art blood pressure cuff device.

Who is the target audience for the new device from LiveCare Inc. (LVCE)?

The device is specifically designed for individuals with high blood pressure, congestive heart failure, hypertension, and diabetes.

What sets LiveCare Health apart from other healthcare solutions?

LiveCare Health offers real-time transmission of device readings to the health center and emphasizes human interaction with patients, providing around-the-clock support.

Why is high blood pressure considered a significant health risk?

High blood pressure, known as the 'silent killer,' can lead to severe complications like heart attacks and strokes without prior symptoms.

How does LiveCare Inc. (LVCE) aim to impact public health with its new device?

LiveCare Inc. aims to enhance life quality for those affected by chronic illnesses by offering accessible and user-friendly solutions for health management.

LIVECARE INC

OTC:LVCE

LVCE Rankings

LVCE Latest News

LVCE Stock Data

20.10M
United States of America